生物活性 | |||
---|---|---|---|
描述 | ML349, identified as a strong and selective inhibitor for APT2 and LYPLA2, has a Ki of 120 nM and an IC50 of 144 nM. It exhibits high selectivity for LYPLA2 over LYPLA1, with Ki values for APT-1 and APT-2 being >10000 nM and 120±20 nM, respectively. Furthermore, ML349 inhibits both LYPLA1 and LYPLA2 with IC50s of >3000 nM and 144 nM, respectively[1][2]. ML348 and ML349 are not associated with a reduction in cell viability; however, they induce a minor activation of the AKT pathway in cells with NRAS mutations[3]. |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
2.20mL 0.44mL 0.22mL |
11.00mL 2.20mL 1.10mL |
22.00mL 4.40mL 2.20mL |
参考文献 |
---|